This article provides a comprehensive, comparative analysis of chimeric antigen receptor (CAR) T-cell constructs engineered to overcome treatment resistance in relapsed/refractory cancers.
This comprehensive review addresses the critical role of ESR1 mutations in driving resistance to endocrine therapy for hormone receptor-positive (HR+) metastatic breast cancer.
This comprehensive guide explores the ELISpot (Enzyme-Linked Immunospot) assay as a critical tool for monitoring antigen-specific immune responses in cancer research and immunotherapy development.
This article explores the critical role of epidermal growth factor receptor (EGFR) heterogeneity in the development of intrinsic drug tolerance in cancers such as non-small cell lung cancer (NSCLC).
This article provides a comprehensive analysis for researchers and drug development professionals on the paradigm shift from traditional, semi-quantitative immunohistochemistry (IHC) scoring to AI-powered digital pathology quantification.
This article provides a comprehensive overview for researchers, scientists, and drug development professionals on the use of DNA methylation signatures for predicting a cancer's tissue of origin.
This comprehensive review synthesizes current research on the biological mechanisms that govern cytotoxic CD8+ T lymphocyte infiltration into solid tumors, a critical determinant of immunotherapy response.
This article provides a detailed guide for researchers and drug development professionals on leveraging multiplex bead-based immunoassays (Luminex xMAP technology) for cytokine profiling within the complex tumor microenvironment (TME).
This review synthesizes the latest evidence for Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) as a pan-cancer cancer stem cell (CSC) marker.
This article provides a comprehensive guide to the Cross-Platform Omics Prediction (CPOP) statistical framework, designed for researchers and drug development professionals.